AAAAAA

   
Results: 1-12 |
Results: 12
Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death (vol 47, pg 1166, 2001)
Authors: Chace, DH DiPierna, JC Mitchell, BL Sgroi, B Hofman, LF Naylor, EW
Citation: Dh. Chace et al., Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death (vol 47, pg 1166, 2001), CLIN CHEM, 47(9), 2001, pp. 1748-1748
Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death
Authors: Chace, DH DiPerna, JC Mitchell, BL Sgroi, B Hofman, LF Naylor, EW
Citation: Dh. Chace et al., Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death, CLIN CHEM, 47(7), 2001, pp. 1166-1182
Errors caused by the use of D,L-octanoylcarnitine for blood-spot calibrators
Authors: Chace, DH DiPerna, JC Adam, BW
Citation: Dh. Chace et al., Errors caused by the use of D,L-octanoylcarnitine for blood-spot calibrators, CLIN CHEM, 47(4), 2001, pp. 758-760
Rapid diagnosis of methylmalonic and propionic acidemias: Quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper bloodspecimens obtained from newborns
Authors: Chace, DH DiPerna, JC Kalas, TA Johnson, RW Naylor, EW
Citation: Dh. Chace et al., Rapid diagnosis of methylmalonic and propionic acidemias: Quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper bloodspecimens obtained from newborns, CLIN CHEM, 47(11), 2001, pp. 2040-2044
Mass spectrometry in the clinical laboratory
Authors: Chace, DH
Citation: Dh. Chace, Mass spectrometry in the clinical laboratory, CHEM REV, 101(2), 2001, pp. 445-477
Medium-chain Acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-Based prospective screening of newborns differ from those observed in patients with clinical symptoms: Identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency
Authors: Andresen, BS Dobrowolski, SF O'Reilly, L Muenzer, J McCandless, SE Frazier, DM Udvari, S Bross, P Knudsen, I Banas, R Chace, DH Engel, P Naylor, EW Gregersen, N
Citation: Bs. Andresen et al., Medium-chain Acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-Based prospective screening of newborns differ from those observed in patients with clinical symptoms: Identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency, AM J HU GEN, 68(6), 2001, pp. 1408-1418
Recoveries of phenylalanine from two sets of dried-blood-spot reference materials: Prediction from hematocrit, spot volume, and paper matrix
Authors: Adam, BW Alexander, JR Smith, SJ Chace, DH Loeber, JG Elvers, LH Hannon, WH
Citation: Bw. Adam et al., Recoveries of phenylalanine from two sets of dried-blood-spot reference materials: Prediction from hematocrit, spot volume, and paper matrix, CLIN CHEM, 46(1), 2000, pp. 126-128
Expansion of newborn screening programs using automated tandem mass spectrometry
Authors: Chace, DH Naylor, EW
Citation: Dh. Chace et Ew. Naylor, Expansion of newborn screening programs using automated tandem mass spectrometry, MENT RET D, 5(2), 1999, pp. 150-154
Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism
Authors: Naylor, EW Chace, DH
Citation: Ew. Naylor et Dh. Chace, Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism, J CHILD NEU, 14, 1999, pp. S4-S8
Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millennium
Authors: Chace, DH DiPerna, JC Naylor, EW
Citation: Dh. Chace et al., Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millennium, ACT PAEDIAT, 88, 1999, pp. 45-47
Validation of accuracy-based amino acid reference materials in dried-bloodspots by tandem mass spectrometry for newborn screening assays
Authors: Chace, DH Adam, BW Smith, SJ Alexander, JR Hillman, SL Hannon, WH
Citation: Dh. Chace et al., Validation of accuracy-based amino acid reference materials in dried-bloodspots by tandem mass spectrometry for newborn screening assays, CLIN CHEM, 45(8), 1999, pp. 1269-1277
Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours
Authors: Chace, DH Sherwin, JE Hillman, SL Lorey, F Cunningham, GC
Citation: Dh. Chace et al., Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours, CLIN CHEM, 44(12), 1998, pp. 2405-2409
Risultati: 1-12 |